|
[1]
|
Li, Y., Teng, D., Shi, X., et al. (2020) Prevalence of Diabetes Recorded in Mainland China Using 2018 Diagnostic Crite-ria from the American Diabetes Association: National Cross Sectional Study. British Medical Journal, 369, m997. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Pugazhenthi, S., Qin, L. and Reddy, P.H. (2017) Common Neurodegenera-tive Pathways in Obesity, Diabetes, and Alzheimer’s Disease. Biochimica et Biophysica Acta (BBA)—Molecular Basis of Disease, 1863, 1037-1045. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
中华医学会糖尿病学分会微血管并发症学组. 中国糖尿病肾脏疾病防治临床指南[J]. 中华糖尿病杂志, 2019, 11(1): 15-28.
|
|
[4]
|
Fox, C.S., Matsushita, K., Woodward, M., et al. (2012) Associations of Kidney Disease Measures with Mortality and End-Stage Renal Disease in Individuals with and without Diabetes: A Meta-Analysis. The Lancet, 380, 1662-1673. [Google Scholar] [CrossRef]
|
|
[5]
|
中华医学会糖尿病学分会. 中国2型糖尿病防治指南(2020年版) [J]. 中华内分泌代谢杂志, 2021, 37(4): 311-398.
|
|
[6]
|
Yoo, D., Kim, R., Jung, Y.J., Han, K., Shin, C.M. and Lee, J.Y. (2020) Serum Gamma-Glutamyltransferase Activity and Parkinson’s Disease Risk in Men and Women. Scientific Reports, 10, Article No. 1258. [Google Scholar] [CrossRef] [PubMed]
|
|
[7]
|
Praetorius Björk, M. and Johansson, B. (2018) Gam-ma-Glutamyltransferase (GGT) as a Biomarker of Cognitive Decline at the End of Life: Contrasting Age and time to Death Trajectories. International Psychogeriatrics, 30, 981-990. [Google Scholar] [CrossRef]
|
|
[8]
|
Hong, S.H., Han, K., Park, S., et al. (2020) Gamma-Glutamyl Transferase Variability and Risk of Dementia in Diabetes Mellitus: A Nationwide Population-Based Study. The Journal of Clinical Endocrinology & Metabolism, 105, e119-e129. [Google Scholar] [CrossRef] [PubMed]
|
|
[9]
|
王君, 肖胜春, 朱秋月. γ-谷氨酰转肽酶与2型糖尿病及糖尿病性肾病的相关性分析[J]. 上海医药, 2018, 39(23): 94-96.
|
|
[10]
|
Chen, T., Ren, Y., Gao, Y. and Tian, H. (2017) Serum Gamma-Glutamyl Transferase and Ferritin Synergis-tically Associated with the Rate of Chronic Kidney Disease. Disease Markers, 2017, Article ID; 9765259. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Bennett, S., Grant, M.M. and Aldred, S. (2009) Oxidative Stress in Vascular Dementia and Alzheimer’s Disease: A Common Pathology. Journal of Alzheimer’s Disease, 17, 245-257. [Google Scholar] [CrossRef]
|
|
[12]
|
孙虹云, 付丽琳. 糖尿病肾病碱性磷酸酶升高原因分析[J]. 淮海医药, 1999(S1): 18.
|
|
[13]
|
Zhao, L., Li, L., Ren, H., et al. (2020) Association between Serum Alkaline Phosphatase and Renal Outcome in Patients with Type 2 Diabetes Mellitus. Renal Failure, 42, 818-828. [Google Scholar] [CrossRef]
|
|
[14]
|
Agarwal, S.K., Saikia, U.K., Sarma, D. and Devi, R. (2018) Assessment of Glomerular and Tubular Function in the Evaluation of Diabetic Nephropathy: A Cross-Sectional Study. Indian Journal of Endocrinology and Metabolism, 22, 451-456. [Google Scholar] [CrossRef]
|
|
[15]
|
陈燕, 钟静, 董加宝. 尿微量白蛋白联合血清碱性磷酸酶、胱抑素C水平与早期2型糖尿病肾病的相关性研究[J]. 中国医刊, 2020, 55(7): 740-743.
|
|
[16]
|
Won, O.S., Han, K.H., Han, S.Y. and Nick, A. (2015) Associations between Renal Hyperfiltration and Serum Alkaline Phosphatase. PLoS ONE, 10, e0122921. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
张韵倩, 徐丛荣, 池飞燕. 血清胱抑素C、β-2微球蛋白和尿微量白蛋白/肌酐比值在早期2型糖尿病肾病中的诊断价值[J]. 医学理论与实践, 2017, 30(4): 583-584.
|
|
[18]
|
邢辙, 栾新红. 视黄醇结合蛋白4的生物学作用研究进展[J]. 中国家禽, 2017, 39(8): 45-47.
|
|
[19]
|
Fleisch, A.F., Kloog, I., Luttmann-Gibson, H., Gold, D.R., Oken, E. and Schwartz, J.D. (2016) Air Pollution Exposure and Gestational Diabetes Mellitus among Pregnant Women in Massachusetts: A Cohort Study. Environmental Health, 15, Article No. 40. [Google Scholar] [CrossRef] [PubMed]
|
|
[20]
|
Mahfouz, M.H., Assiri, A.M. and Mukhtar, M.H. (2016) As-sessment of Neutrophil Gelatinase-Associated Lipocalin (NGAL) and Retinol-Binding Protein 4 (RBP4) in Type 2 Dia-betic Patients with Nephropathy. Biomarker Insights, 11, 31-40. [Google Scholar] [CrossRef]
|
|
[21]
|
陈昊珺, 王斌礼, 杨晓莉. 血清视黄醇结合蛋白4联合尿白蛋白/肌酐比值在妊娠期糖尿病早期肾损伤诊断中的价值[J]. 中国妇幼保健, 2019, 34(22): 5141-5143.
|
|
[22]
|
Su, Y., Huang, Y., Jiang, Y. and Zhu, M. (2020) The Association be-tween Serum Retinol-Binding Protein 4 Levels and Cardiovascular Events in Patients with Chronic Kidney Disease. La-boratory Medicine, 51, 491-497. [Google Scholar] [CrossRef] [PubMed]
|
|
[23]
|
常杰. 血清视黄醇结合蛋白与尿微量白蛋白在2型糖尿病早期肾病中的诊断价值探讨[J]. 中国全科医学, 2020, 23(S2): 132-133.
|
|
[24]
|
Miraghajani, M., Zaghian, N., Dehkohneh, A., Mirlohi, M. and Ghiasvand, R. (2019) Probiotic Soy Milk Consumption and Renal Function among Type 2 Diabetic Pa-tients with Nephropathy: A Randomized Controlled Clinical Trial. Probiotics and Antimicrobial Proteins, 11, 124-132. [Google Scholar] [CrossRef] [PubMed]
|
|
[25]
|
Pucci, L., Triscornia, S., Lucchesi, D., et al. (2007) Cystatin C and Estimates of Renal Function: Searching for a Better Measure of Kidney Function in Diabetic Patients. Clinical Chemistry, 53, 480-488. [Google Scholar] [CrossRef] [PubMed]
|
|
[26]
|
Perlemoine, C., Beauvieux, M.C., Rigalleau, V., et al. (2003) Interest of Cystatin C in Screening Diabetic Patients for Early Impairment of Renal Function. Metabolism, 52, 1258-1264. [Google Scholar] [CrossRef]
|
|
[27]
|
Mussap, M., Dalla Vestra, M., Fioretto, P., et al. (2002) Cystatin C Is a More Sensitive Marker than Creatinine for the Estimation of GFR in Type 2 Diabetic Patients. Kidney In-ternational, 61, 1453-1461. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Chen, H. and Li, H. (2017) Clinical Implication of Cystatin C and β2-Microglobulin in Early Detection of Diabetic Nephropathy. Clinical Laboratory, 63, 241-247. [Google Scholar] [CrossRef]
|
|
[29]
|
Salem, N.A., El Helaly, R.M., Ali, I.M., et al. (2020) Urinary Cyclophilin A and serum Cystatin C as Biomarkers for Diabetic Nephropathy in Children with Type 1 Diabetes. Pediat-ric Diabetes, 21, 846-855. [Google Scholar] [CrossRef] [PubMed]
|
|
[30]
|
Khosla, U.M., Zharikov, S., Finch, J.L., et al. (2005) Hyperuricemia In-duces Endothelial Dysfunction. Kidney International, 67, 1739-1742. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Sautin, Y.Y., Nakagawa, T., Zharikov, S. and Johnson, R.J. (2007) Adverse Effects of the Classic Antioxidant Uric Acid in Adipocytes: NADPH Oxidase-Mediated Oxida-tive/Nitrosative Stress. American Journal of Physiology—Cell Physiology, 293, C584-C596. [Google Scholar] [CrossRef] [PubMed]
|
|
[32]
|
Roy, D., Perreault, M. and Marette, A. (1998) Insulin Stimulation of Glucose Uptake in Skeletal Muscles and Adipose Tissues in Vivo Is NO Dependent. American Journal of Physiology, 274, E692-E699. [Google Scholar] [CrossRef]
|
|
[33]
|
Wang, T.G., Bi, Y.F., Xu, M., et al. (2011) Serum Uric Acid Associates with the Incidence of Type 2 Diabetes in a Prospective Cohort of Middle-Aged and Elderly Chinese. Endocrine, 40, 109-116. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Taniguchi, Y., Hayashi, T., Tsumura, K., Endo, G., Fujii, S. and Okada, K. (2001) Serum Uric Acid and the Risk for Hypertension and Type 2 Diabetes in Japanese Men: The Osaka Health Survey. Journal of Hypertension, 19, 1209-1215. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Kentaro, K., Masako, K., Tsuyoshi, M., et al. (2013) An Association between Uric Acid Levels and Renal Arteriolopathy in Chronic Kidney Disease: A Biopsy-Based Study. Hypertension Research, 36, 43-49. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
Yan, D., Tu, Y., Jiang, F., et al. (2017) Uric Acid Is Independently As-sociated with Diabetic Kidney Disease: A Cross-Sectional Study in a Chinese Population. PLoS ONE, 10, e0129797. [Google Scholar] [CrossRef] [PubMed]
|
|
[37]
|
梁珊珊, 刘英, 周朝琼, 张玫, 黄亨建. 血尿酸与糖尿病肾病患者肾脏功能减退的相关性分析[J]. 标记免疫分析与临床, 2020, 27(1): 6-9+36.
|